Showing 108 of 108on this page. Filters & sort apply to loaded results; URL updates for sharing.108 of 108 on this page
Freenome to Report Third Quarter 2026 Financial Results on November 10 ...
Freenome Inc. Q3FY26 Results: Release date set for November 10
Freenome to report Q3 2026 financial results on... | Pluang
Freenome Announces Expanded Artificial Intelligence and Deep Learning ...
Freenome Closes $270 Million Series C Financing to Advance Novel ...
ARK Sells Personalised Shares, Buys Freenome | News Minimalist
Freenome Highlights Improved SimpleScreen CRC Performance Data At ACG ...
Freenome secures FDA nod for blood-based colorectal cancer test ...
Freenome Completes De-SPAC, Begins Trading on Nasdaq - TipRanks.com
Cathie Wood’s ARK Sells Personalised, Buys Freenome and Rocket Lab ...
Freenome Announces Exclusive Agreement with Roche to Expand Technology ...
Cathie Wood’s ARK sells Personalised stock, buys Freenome shares By ...
FDA Clears Freenome SimpleScreen CRC; Abbott to Sell
Freenome Funding & Investors - Post-IPO Equity - South San Francisco ...
FRNM | Freenome Inc. Analyst Estimates | MarketWatch
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based ...
Freenome Stock Price | FRNM Stock Quote, News, and History | Markets ...
Freenome begins trading on Nasdaq after $310 million business combination
Freenome (FRNM) — Stock After Hours
Freenome Inc IPO History, Live Price & Valuation | IPO Tracker
Freenome inks deals to list stock and raise $330M | MedTech Dive
Freenome details SPAC deal and $132.6M loss | FRNM 8-K Filing
BTIG initiates Freenome stock with buy rating on cancer test potential ...
ARK Кэти Вуд продаёт акции Personalised, покупает Freenome От Investing.com
Freenome plans Q3 2026 results release for Nov. 10 | FRNM Stock News
Freenome Reveals Potential to Use Platform for Patient Monitoring - AI ...
ARK van Cathie Wood verkoopt Personalised-aandelen, koopt Freenome Door ...
Freenome builds next generation of cancer detection technology | Google ...
Freenome and Roche partner on cancer screening technology for ex-US markets
Jobs at Freenome (2026) | 24 Open Positions | Biohired
Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC ...
Freenome - FRNM - Stock Price & News | The Motley Fool
Abbott Laboratories Aktie: Freenome meldet bessere Sensitivität beim ...
Roche, Freenome ink global deal for blood-based colon cancer test - San ...
Freenome Amasses $270 Million for Colorectal Cancer Blood Testing - WSJ
Freenome Welcomes Rob Guigley as New Chief Commercial Officer ...
Freenome Raises $65M in Series A from Andreessen Horowitz, GV and others
FREENOME
Freenome kicks off study melding multiomics blood test, real-world data ...
Roche leads Freenome Inc US$257m financing - European Biotechnology ...
Oncimmune sells its diagnostic business to Freenome for £13 million ...
Liquid biopsy startup Freenome lands $5.5 million led by Andreessen ...
Freenome puts down $16M to pick up fellow cancer test maker Oncimmune ...
Is Freenome a Leading Cancer Blood-Testing Company? - Index Investing News
Exact Sciences Announces Exclusive License with Freenome for Blood ...
Freenome Initiates Clinical Study of Blood Test for Early Lung Cancer ...
Freenome raises $160m to advance cancer diagnostic test
Freenome Careers | View Current Job Opportunities
Freenome to cut more than 100 employees in restructuring | MedTech Dive
Freenome to Go Public in $1.1B SPAC Deal Backed by Perceptive and RA ...
Freenome Holdings, Inc. Chooses SYSPRO ERP to Help Enable Next ...
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide ...
Walgreens and Freenome Partner to Increase Diversity in Research ...
Freenome and NVIDIA Expand AI for Multi-Cancer Detection
FREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTD
Freenome raises $254m for cancer tests, and other financings | pharmaphorum
Freenome posts pivotal liquid biopsy data as FDA filing nears completion
Freenome IPO: Early Cancer Detection & Liquid Biopsy Revolution
Freenome teams up with Roche for cancer screening tests | MobiHealthNews
Freenome Teams Up with Exact Sciences for Colorectal Cancer Blood Test ...
Freenome Presents Data Demonstrating the Importance of Clinical Test ...
FREENOME PRESENTS RESEARCH HIGHLIGHTING THE PROMISE OF IDENTIFYING DRUG ...
What are the Porter's Five Forces of Freenome ...
Cancer testing company Freenome to lay off 100 employees – Biotech Networks
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung ...
Freenome Partners with Siemens Healthineers for Breast Cancer Research ...
Freenome liberated with $254M infusion for cancer testing | BioWorld
GenomeWeb Best Places to Work Winner, 251+ Employees: Freenome | GenomeWeb
Roche inks deal for rights to Freenome cancer tests outside US (Medtech ...
Walgreens and Freenome Announce Multi-year Partnership | Applied ...
Freenome Processes First Commercial Patient Samples for SimpleScreen ...
Freenome, PCSC agree $1.1B SPAC deal, add $240M PIPE | PCSC Stock News
Investor Relations | Freenome, Inc.
Freenome, Inc. (FRNM) Earnings Dates & Report | Seeking Alpha
Freenome, Inc. Common stock (FRNM) earnings history, price reaction ...
Freenome, Inc. Stock (FRNM) - Quote Nasdaq- MarketScreener
Exact Sciences Stock Dives; Is It 'Throwing Good Money At Bad' With The ...
Freenome, Inc. - FRNM - Seasonality
Historical FRNM stock prices (quote) - Freenome, Inc. Common Stock
Freenome’s colorectal cancer blood test data underwhelm analysts ...
NASDAQ, FRNM End of Day and Historical Stock Data [Freenome Inc]
Exact Sciences Announces Expiration Of The HSR Waiting Period For ...
Enhancing Large-Scale Data Quality and Compliance: How Medrio Empowers ...
Roche inks $200M pact for Freenome's cancer screening blood test
Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer ...
AI Diagnostics Market Is Going to Boom | Major Giants Aidoc, Zebra ...
Exact Sciences Licenses Freenome’s Blood-Based Cancer Tests - AI-Tech Park
Roche to bring Freenome's cancer tests abroad in $200M deal
Perceptive Capital Solutions Corp 2025 Annual Report: Business ...
Enhancing Data Quality & Compliance: Freenome's Success
